Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society …

RD Santos, SS Gidding, RA Hegele… - The lancet Diabetes & …, 2016 - thelancet.com
Familial hypercholesterolaemia is common in individuals who had a myocardial infarction at
a young age. As many as one in 200 people could have heterozygous familial …

Genetic and molecular architecture of familial hypercholesterolemia

M Abifadel, C Boileau - Journal of internal medicine, 2023 - Wiley Online Library
Atherosclerotic cardiovascular disease is the leading cause of death globally. Despite its
important risk of premature atherosclerosis and cardiovascular disease, familial …

Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017

AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …

Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials

F Fogacci, N Ferri, PP Toth, M Ruscica, A Corsini… - Drugs, 2019 - Springer
Aim Our aim was to assess the efficacy and safety of mipomersen through a systematic
review of the literature and a meta-analysis of the available clinical studies. Methods A …

Machine learning methods for hypercholesterolemia long-term risk prediction

E Dritsas, M Trigka - Sensors, 2022 - mdpi.com
Cholesterol is a waxy substance found in blood lipids. Its role in the human body is helpful in
the process of producing new cells as long as it is at a healthy level. When cholesterol …

Progress and perspectives in plant sterol and plant stanol research

PJH Jones, M Shamloo, DS MacKay… - Nutrition …, 2018 - academic.oup.com
Current evidence indicates that foods with added plant sterols or stanols can lower serum
levels of low-density lipoprotein cholesterol. This review summarizes the recent findings and …

Significance of lipoprotein (a) levels in familial hypercholesterolemia and coronary artery disease

S Li, NQ Wu, CG Zhu, Y Zhang, YL Guo, Y Gao, XL Li… - Atherosclerosis, 2017 - Elsevier
Background and aims Patients with familial hypercholesterolemia (FH) are often
characterized by premature coronary artery disease (CAD) with heterogeneity at onset. The …

Lumping versus splitting: how to approach defining a disease to enable accurate genomic curation

C Thaxton, J Goldstein, M DiStefano, K Wallace… - Cell genomics, 2022 - cell.com
The dilemma of how to categorize and classify diseases has been debated for centuries.
The field of medical genetics has historically approached nosology based on clinical …

Update of the Brazilian guideline for familial hypercholesterolemia–2021

MCO Izar, VZR Giraldez, A Bertolami… - Arquivos brasileiros de …, 2021 - SciELO Brasil
Financial declaration A-Economically relevant payments of any kind made to (i) you,(ii) your
spouse/partner or any other person living with you,(iii) any legal person in which any of …

A half-century history of applications of antisense oligonucleotides in medicine, agriculture and forestry: we should continue the journey

VV Oberemok, KV Laikova, AI Repetskaya, IM Kenyo… - Molecules, 2018 - mdpi.com
Antisense oligonucleotides (ASO), short single-stranded polymers based on DNA or RNA
chemistries and synthesized in vitro, regulate gene expression by binding in a sequence …